20mM Tris-HCl (pH 7.5), 2mM EGTA, 2mM EDTA, 1mM DTT, 10mM potassium phosphate (pH 7.5), 50% glycerol and 0.05% Triton® X-100.
PKC Activation 5X Buffer
1.6mg/ml phosphatidylserine, 0.16mg/ml diacylglycerol, 100mM Tris-HCl (pH 7.5), 50mM MgCl2.
PKC Coactivation 5X Buffer
1.25mM EGTA, 2mM CaCl2, 0.5mg/ml BSA.
Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.
For product intended use please see Patents & Disclaimers tab.
V4504, V4505 For Research Use Only. Not for Use in Diagnostic Procedures.
Patents - Disclaimers
V4505 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.
V4505 U.S. Pat. No. 7,700,310 and other patents and patents pending.
V4505 U.S. Pat. Nos. 7,741,067, 8,361,739 and 8,603,767 and other patents and patents pending.
V4505 U.S. Pat. Nos. 6,602,677, 7,241,584, 8,030,017 and 8,822,170 and other patents and patents pending.
V4505 U.S. Pat. No. 8,183,007 and other patents and patents pending.
V4505 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.